Tag: Pfizer

Posted on

Pfizer, Boehringer’s Drug Helped to Delay Asthma Attacks – Bloomberg

Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Bloomberg
A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium and …
Boehringer's COPD drug shows promise in asthmaPharma Times
COPD drug cuts asthma exacerbationsGP online
First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated …The Herald | HeraldOnline.com
Financial Post
all 56 news articles »

View full post on asthma – Google News

Posted on

Pfizer, Boehringer’s Drug Helped to Delay Asthma Attacks – Businessweek

Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Businessweek
A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium, cut the …
First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated …Sacramento Bee
Phase III results: tiotropiumA Respimat® significantly reduces exacerbations …Financial Post

all 13 news articles »

View full post on asthma – Google News

Posted on

Pfizer wins right to challenge Prempro damages award; Asthma market flat until … – FiercePharma

Pfizer wins right to challenge Prempro damages award; Asthma market flat until …
FiercePharma
Item > The asthma drug market will remain flat at around $14.4 billion through 2020, thanks in part to generic rivals for Merck's ($MRK)Singulair, Decision Resources concludes. Release > Teva Pharmaceutical Industries ($TEVA) won an appeals court's …

View full post on asthma – Google News

Posted on

Pfizer returns asthma drug development to Rigel – Ventura County Star

Pfizer returns asthma drug development to Rigel
Ventura County Star
(AP) – Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage …
Rigel Assumes Development Responsibility For Inhaled AsthmaBioResearch Online (press release)
Losing Biobucks as Pharma Reshuffles Its DeckSeeking Alpha
Pfizer returns asthma drug candidate rights to Rigel Pharma; latter narrows lossesThe Pharma Letter
Pharma Times
all 6 news articles »

View full post on asthma – Google News

Posted on

Pfizer returns asthma drug development to Rigel – Forbes

Pfizer returns asthma drug development to Rigel
Forbes
Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage company said …
Rigel says Pfizer returns asthma therapy rightsReuters
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer returns allergic asthma drug to RigelFierceBiotech
Xconomy
all 27 news articles »

View full post on asthma – Google News

Posted on

Pfizer returns allergic asthma drug to Rigel – FierceBiotech

Pfizer returns allergic asthma drug to Rigel
FierceBiotech
Pfizer's decision to ends its allergy and respiratory R&D work has prompted the company return rights to the R343 program for allergic asthma to Rigel Pharmaceuticals. The drug has shown promise in Phase I trials and Rigel plans to begin designing a …
Rigel says Pfizer returns asthma therapy rightsReuters
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer Hands Back Rigel DrugXconomy

all 16 news articles »

View full post on asthma – Google News

Posted on

Rigel says Pfizer returns asthma therapy rights – Reuters

Rigel says Pfizer returns asthma therapy rights
Reuters
May 6 (Reuters) – Rigel Pharmaceuticals Inc said Pfizer Inc has returned the rights to Rigel's inhaled asthma therapy, following the world's biggest drugmaker's decision to exit research and development in the allergy and respiratory therapeutic area. …
Rigel Assumes Development Responsibility for Inhaled Asthma TherapyPR Newswire (press release)
Pfizer Hands Back Rigel DrugXconomy

all 12 news articles »

View full post on asthma – Google News